Drug Trial Radar · NCT06808984
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
120
Planned (sponsor's estimate)
Start
Jun 9, 2025
Primary completion
Nov 26, 2027
Study completion Jan 7, 2028
Sponsor
- Lead sponsor
- CelgeneBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Feb 5, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 55 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a study to evaluate the efficacy, safety, and tolerability of BMS-986368, a FAAH/MAGL inhibitor, for the treatment of agitation in participants with Alzheimer's Disease.
Conditions
- Agitation
- Alzheimer Disease
Interventions
BMS-986368Drug
Specified dose on specified days
PlaceboDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Cohen-Mansfield Agitation Inventory (CMAI) total score from baselineTime frame: Up to Week 8
Locations
77 sites in 4 countries. Site status is shown where the registry gives one.
Local Institution - 0046
Homewood, Alabama · Not yet recruiting
University of Alabama - Huntsville Regional Medical Campus
Huntsville, Alabama · Recruiting
Local Institution - 0048
Phoenix, Arizona · Completed
Local Institution - 0040
Scottsdale, Arizona · Not yet recruiting
Local Institution - 0017
Anaheim, California · Not yet recruiting
Inland Psychiatric Medical Group.
Chino, California · Recruiting
Kaizen Brain Center
La Jolla, California · Recruiting
Local Institution - 0052
La Jolla, California · Completed
Shreenath Clinical Service - Lakewood
Lakewood, California · Recruiting
Local Institution - 0043
Sherman Oaks, California · Completed
Next Level Clinical Trials
West Covina, California · Recruiting
Local Institution - 0028
West Hills, California · Completed
University of Colorado Anschutz Medical Campus
Aurora, Colorado · Recruiting
Georgetown University
Washington D.C., District of Columbia · Recruiting
Local Institution - 0053
Washington D.C., District of Columbia · Withdrawn
Arrow Clinical Trials
Daytona Beach, Florida · Recruiting
ClinCloud
Maitland, Florida · Recruiting
Local Institution - 0007
Maitland, Florida · Not yet recruiting
Local Institution - 0022
Miami, Florida · Withdrawn
Local Institution - 0010
Miami, Florida · Completed
Local Institution - 0001
Tampa, Florida · Not yet recruiting
University of South Florida, Department of Psychiatry and Behavioral Neurosciences
Tampa, Florida · Recruiting
Charter Research - Lady Lake
The Villages, Florida · Recruiting
Local Institution - 0026
Atlanta, Georgia · Completed
CenExel iResearch, LLC
Decatur, Georgia · Recruiting
CenExel iResearch, LLC
Savannah, Georgia · Recruiting
Local Institution - 0004
Honolulu, Hawaii · Completed
Local Institution - 0086
Elgin, Illinois · Withdrawn
Local Institution - 0011
Marrero, Louisiana · Not yet recruiting
K2 Medical Research
Foxborough, Massachusetts · Recruiting
Local Institution - 0051
South Dartmouth, Massachusetts · Not yet recruiting
Local Institution - 0088
Sterling Heights, Michigan · Not yet recruiting
Local Institution - 0061
Missoula, Montana · Completed
Be Well Clinical Studies - Omaha
Omaha, Nebraska · Recruiting
Local Institution - 0041
Las Vegas, Nevada · Completed
Local Institution - 0059
Livingston, New Jersey · Not yet recruiting
Ocean Medical Research
Toms River, New Jersey · Recruiting
University at Buffalo - UBMD Neurology
Buffalo, New York · Recruiting
The Feinstein Institute for Medical Research
Manhasset, New York · Recruiting
Mid Hudson Medical Research
New Windsor, New York · Recruiting
Showing 40 of 77 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.